Trivikram Rajkhowa

Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation

Farhad Ravandi, Mona Lisa Alattar, Michael R. Grunwald et al. · Blood · 2013 · 373 citations · Full text

Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants

Allison Galanis, Hayley Ma, Trivikram Rajkhowa et al. · Blood · 2013 · 247 citations · Full text

FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML

Keith W. Pratz, Takashi Sato, Kathleen M. Murphy et al. · Blood · 2009 · 238 citations

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia

Yi‐Bin Chen, Shuli Li, Andrew A. Lane et al. · Biology of Blood and Marrow Transplantation · 2014 · 233 citations · Full text

Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML

Amy Sexauer, Alexander E. Perl, Xiaochuan Yang et al. · Blood · 2012 · 170 citations · Full text